Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma

Leukemia, Published online: 17 October 2023; doi:10.1038/s41375-023-02065-xBispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma

Source: Leukemia - October 17, 2023 Category: Hematology Authors: Chenggong Li Jia Xu Wenjing Luo Danying Liao Wei Xie Qiuzhe Wei Yinqiang Zhang Xindi Wang Zhuolin Wu Yun Kang Jin ’e Zheng Wei Xiong Jun Deng Yu Hu Heng Mei Source Type: research